First Trust Health Care AlphaDEX Fund (FXH) seeks to track the StrataQuant Health Care Index, which uses a quantitative stock selection methodology to identify undervalued healthcare companies with strong growth potential. This sector-focused equity ETF provides exposure to U.S. healthcare stocks including pharmaceuticals, biotechnology, medical devices, and healthcare services companies.
How It Works
FXH employs First Trust's proprietary AlphaDEX methodology, which ranks healthcare stocks based on growth and value factors including price appreciation, sales-to-price ratio, and one-year sales growth. The top-ranked stocks receive higher weightings than traditional market-cap weighting would suggest. The fund rebalances quarterly to capture changing factor scores and maintain sector allocation targets. Holdings typically range from 75-100 healthcare companies with enhanced weightings toward stocks exhibiting the strongest factor characteristics.
Key Features
- Uses quantitative factor-based weighting instead of market-cap weighting to potentially outperform traditional healthcare sector ETFs
- Focuses exclusively on U.S. healthcare sector with enhanced exposure to undervalued companies showing growth momentum
- Quarterly rebalancing captures changing fundamentals and factor scores across pharmaceutical, biotech, and medical device companies
Risks
- This ETF can lose significant value during healthcare sector downturns, potentially declining 40-50% when drug approvals fail or regulatory changes threaten industry profits
- Factor-based weighting may underperform during periods when growth and value metrics fail to predict stock performance accurately
- Concentrated sector exposure means the fund lacks diversification benefits, making it vulnerable to healthcare-specific regulatory, patent, and competitive risks
Who Should Own This
Best suited as a satellite holding (5-15% of equity allocation) for investors with medium-to-high risk tolerance and 3+ year time horizons seeking enhanced healthcare sector exposure. Appropriate for those who believe factor-based stock selection can outperform market-cap weighting in healthcare. Works well for tactical sector rotation strategies or complementing broad market ETFs.